Furthermore, NETs can also shield tumour cells from cytotoxicity, as mediated by CD8+ T cells and NK cells, by obstructing close contact with these cytotoxic immune cells [279], indicating that the combination of NET blockade with immunotherapies, such as immune checkpoint inhibitors, represents a promising strategy to prevent metastatic progression. Here, CD8A is linked to neoplasm.